A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
<h4>Background</h4>Human African trypanosomiasis (HAT), also known as sleeping sickness, is a parasitic tropical disease. It progresses from the first, haemolymphatic stage to a neurological second stage due to invasion of parasites into the central nervous system (CNS). As treatment dep...
Main Authors: | Alexandre Hainard, Natalia Tiberti, Xavier Robin, Veerle Lejon, Dieudonné Mumba Ngoyi, Enock Matovu, John Charles Enyaru, Catherine Fouda, Joseph Mathu Ndung'u, Frédérique Lisacek, Markus Müller, Natacha Turck, Jean-Charles Sanchez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-06-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19554086/?tool=EBI |
Similar Items
-
New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients
by: Natalia Tiberti, et al.
Published: (2013-12-01) -
Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.
by: Natalia Tiberti, et al.
Published: (2013-01-01) -
A CATT negative result after treatment for human African trypanosomiasis is no indication for cure.
by: Veerle Lejon, et al.
Published: (2010-01-01) -
Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.
by: Natalia Tiberti, et al.
Published: (2012-01-01) -
Neopterin and CXCL-13 in Diagnosis and Follow-Up of Trypanosoma brucei gambiense Sleeping Sickness: Lessons from the Field in Angola
by: Julien Bonnet, et al.
Published: (2019-01-01)